Regeneron pharmaceuticals, inc. (REGN)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Dec'09
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value

2,208

1,617

1,384

1,045

1,708

1,467

1,087

917

1,019

812

792

744

811

535

920

646

604

809

654

390

507

648

646

600

461

535

263

381

180

230

118

171

394

483

206

254

135

112

325

112

207

Marketable securities

1,795

1,596

1,493

1,624

1,523

1,342

1,104

765

605

596

586

523

495

503

488

398

244

236

241

213

234

251

395

216

186

158

182

155

127

77

143

129

37

43

39

55

91

136

153

194

134

Accounts receivable - trade, net

2,063

2,100

2,027

1,920

1,728

1,723

1,665

1,534

1,531

1,538

1,532

1,420

1,339

1,343

1,332

1,431

1,450

1,152

1,088

1,071

1,015

739

673

664

801

787

855

767

703

593

506

349

159

28

3

2

3

2

3

4

2

Accounts Receivable, Related Parties, Current

468

260

345

252

287

226

269

243

168

193

217

221

214

92

124

138

173

153

199

197

159

111

110

116

118

104

136

108

98

99

94

85

78

74

74

81

84

79

79

91

62

Accounts receivable - other

401

425

286

283

289

293

267

261

243

242

221

203

195

175

187

181

240

162

151

125

163

125

142

112

127

63

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

1,480

1,415

1,344

1,317

1,208

1,151

1,039

928

820

726

641

554

466

399

345

316

303

238

190

171

133

128

120

109

86

70

-

-

-

28

-

-

-

-

-

-

-

-

-

-

-

Deferred tax assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

69

62

-

49

37

36

44

39

38

99

148

-

-

-

0

-

-

-

-

-

-

-

Prepaid expenses and other current assets

226

273

226

208

182

243

284

163

155

225

143

193

146

130

103

96

115

163

89

43

34

79

61

60

52

32

156

108

97

28

84

32

26

35

15

19

10

26

14

16

18

Total current assets

8,644

7,689

7,109

6,651

6,928

6,447

5,719

4,814

4,544

4,335

4,135

3,860

3,669

3,180

3,501

3,209

3,133

2,915

2,675

2,283

2,310

2,084

2,200

1,918

1,871

1,796

1,634

1,561

1,307

1,206

948

769

696

665

339

413

325

357

575

417

425

Restricted cash and marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

8

8

8

8

8

7

8

8

7

7

3

3

1

Marketable securities

3,236

3,256

3,112

2,884

2,339

1,755

1,873

2,044

1,821

1,486

1,327

1,064

967

864

777

589

555

632

681

589

483

460

453

550

534

389

329

173

346

271

312

288

254

275

258

251

373

370

37

70

47

Property, Plant, And Equipment And Finance Lease Right-Of-Use Asset, After Accumulated Depreciation And Amortization

2,944

2,890

2,771

2,676

2,612

2,575

2,524

2,461

2,394

2,358

2,274

2,261

2,277

2,083

1,872

1,772

1,666

1,594

1,475

1,326

1,110

974

818

707

600

526

453

419

392

379

372

372

369

367

363

361

357

347

318

292

259

Deferred tax assets

771

824

808

821

829

828

562

545

532

506

927

882

866

825

655

626

543

461

346

323

289

315

263

270

248

231

218

208

201

192

-

-

-

0

-

-

-

-

-

-

-

Other noncurrent assets

161

144

137

139

144

127

125

85

78

77

36

36

37

20

20

6

5

5

4

4

4

3

3

8

5

5

4

15

20

23

18

19

20

6

13

12

10

6

6

6

7

Total assets

15,757

14,805

13,939

13,173

12,854

11,734

10,805

9,951

9,372

8,764

8,701

8,106

7,817

6,973

6,828

6,204

5,904

5,609

5,182

4,526

4,198

3,837

3,739

3,456

3,260

2,951

2,640

2,378

2,275

2,080

1,660

1,457

1,350

1,323

983

1,046

1,074

1,089

942

790

741

Liabilities and Equity [Abstract]
Current liabilities:
Accounts payable

347

418

335

244

239

218

172

171

207

178

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other current liabilities

1,143

1,211

821

876

741

772

781

670

666

637

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, current

-

-

-

-

-

452

-

-

-

320

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

818

716

1,061

879

714

759

733

644

577

529

462

483

337

283

237

250

219

153

145

111

124

126

106

95

78

81

58

53

74

58

49

Capital and facility lease obligations

-

-

-

-

-

-

-

-

-

-

0

0

7

129

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities - Sanofi

85

85

-

-

-

-

-

-

-

-

0

0

0

1

3

3

13

13

2

2

2

97

1

1

1

0

0

0

1

1

1

1

1

1

0

0

0

0

0

0

0

Total current liabilities

2,055

2,096

1,765

1,713

1,511

1,442

1,417

1,331

1,265

1,135

1,138

1,029

1,308

1,241

961

951

919

811

734

601

536

654

410

351

305

298

268

203

197

163

178

183

160

148

133

135

112

109

133

119

93

Finance lease liabilities

715

713

712

711

709

708

707

705

704

703

702

701

700

351

382

361

362

362

364

357

328

310

276

234

203

184

167

164

159

159

159

159

159

159

159

159

159

159

158

157

109

Deferred revenue, noncurrent

-

-

-

-

-

464

-

-

-

629

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible senior notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30

30

144

146

287

282

326

320

314

308

302

296

290

285

280

275

-

-

-

0

-

-

-

Other noncurrent liabilities

321

317

273

267

376

361

194

190

169

152

125

115

106

100

135

119

120

115

77

76

55

39

23

14

11

11

10

10

8

7

6

7

7

6

7

6

7

7

5

4

3

Total liabilities

3,624

3,715

3,434

3,417

3,410

2,977

2,937

2,765

2,805

2,620

2,649

2,585

2,951

2,524

2,336

2,128

2,139

1,954

1,886

1,188

1,227

1,287

1,187

1,087

1,049

998

950

884

869

835

854

862

846

837

554

568

556

561

594

419

344

Commitments and contingencies

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

0

0

0

0

0

0

0

0

0

0

-

0

-

-

-

Stockholders' Equity Attributable to Parent [Abstract]
Preferred Stock, $.01 par value; 30,000,000 shares authorized; issued and outstanding - none

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Additional paid-in capital

5,211

4,428

4,388

4,263

4,160

3,911

3,841

3,712

3,611

3,512

3,570

3,449

3,190

3,029

3,314

3,156

3,049

3,099

2,880

3,118

2,812

2,450

2,423

2,342

2,236

2,045

1,882

1,827

1,826

1,763

1,795

1,775

1,760

1,754

1,643

1,630

1,609

1,575

1,379

1,368

1,336

Retained earnings

8,004

7,379

6,587

5,918

5,725

5,254

4,433

3,839

3,287

2,946

2,773

2,384

1,997

1,748

1,495

1,230

1,018

852

697

487

292

216

145

65

-27

-92

-189

-330

-418

-517

-987

-1,178

-1,255

-1,267

-1,213

-1,151

-1,089

-1,045

-1,030

-997

-941

Accumulated other comprehensive (loss) income

-9

21

16

15

2

-12

-10

-11

-15

0

23

2

-5

-12

-2

5

4

8

7

19

47

52

26

4

1

-1

-2

-3

-1

-1

-1

-2

-1

-1

-1

-0

-2

-2

-0

-0

1

Treasury Stock, at cost; 5,683,562 shares in 2020 and 4,860,123 shares in 2019

1,073

739

488

441

444

396

396

353

316

316

316

316

316

316

316

316

307

306

288

287

181

169

43

-43

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

12,133

11,089

10,504

9,755

9,444

8,757

7,868

7,186

6,567

6,144

6,051

5,520

4,866

4,449

4,491

4,076

3,765

3,654

3,296

3,338

2,971

2,550

2,551

2,368

2,211

1,952

1,690

1,493

1,406

1,245

806

594

504

485

428

478

518

527

348

371

396

Total liabilities and stockholders' equity

15,757

14,805

13,939

13,173

12,854

11,734

10,805

9,951

9,372

8,764

8,701

8,106

7,817

6,973

6,828

6,204

5,904

5,609

5,182

4,526

4,198

3,837

3,739

3,456

3,260

2,951

2,640

2,378

2,275

2,080

1,660

1,457

1,350

1,323

983

1,046

1,074

1,089

942

790

741

Sanofi
Deferred revenue, current

398

310

427

424

334

246

246

308

231

177

187

184

112

115

105

104

99

101

100

18

19

15

13

12

12

12

13

14

15

17

19

21

20

20

19

19

19

19

19

19

17

Deferred revenue, noncurrent

16

27

551

544

633

279

421

339

406

379

408

443

520

503

529

549

565

582

599

46

48

62

75

75

73

76

77

78

76

76

77

78

83

86

88

91

94

97

99

96

90

Other noncurrent liabilities

450

482

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other
Deferred revenue, current

81

71

181

168

196

205

216

180

160

142

132

127

126

116

137

84

73

51

54

51

51

58

57

54

53

34

34

34

34

33

33

33

32

31

33

33

33

35

38

41

27

Deferred revenue, noncurrent

65

77

131

181

178

184

197

199

257

249

274

295

316

327

327

146

170

82

78

76

114

72

114

128

128

107

111

119

125

131

141

149

154

162

166

174

183

188

197

42

46

Class A Stock
Common stock

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

0

0

0

0

0

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common Stock [Member]
Common stock

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

Total stockholders' equity

0

0

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-